RNA-Based Therapies Back In Spotlight As Chinese Biotechs Raise $366m

 
• By Dexter Jie Yan
fund raising
Investors reignited interest in Chinese biotechs focused on nucleic acid therapeutics • Source: Alamy

More from China

More from Focus On Asia